Skip to content
Home/Companies/Biotech/Bluu Biosciences

Bluu Biosciences

Biotech·Germany·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Bluu Biosciences?

Bluu Biosciences is a German Biotech company, currently owned by DX Ventures since 2021.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
DX Ventures
Investor
DX Ventures
DX Ventures (CVC Evergreen Vehicle) · 2021 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from DX Ventures (CVC Evergreen Vehicle)

Other portfolio companies in the same fund.

Akiba
Active
South Africa
Impossible Foods
Active
United States
JUST
JUST
Active
FintechUnited States
Pop Meals
Active
Malaysia
Alpagga
Active
E-commerceFrance· 2024
Mine.is
Active
E-commerceSouth Korea· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Bluu Biosciences?

Bluu Biosciences is currently owned by DX Ventures, through DX Ventures (CVC Evergreen Vehicle), since 2021.

When did DX Ventures acquire Bluu Biosciences?

DX Ventures acquired Bluu Biosciences in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue